FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

396009008: Cyclopenthiazide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1469949017 Cyclopenthiazide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1489637010 Cyclopenthiazide en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cyclopenthiazide Is a Thiazide diuretic true Inferred relationship Existential restriction modifier
Cyclopenthiazide Is a Benzothiadiazine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cyclopenthiazide adverse reaction Causative agent True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Allergy to cyclopenthiazide Causative agent False Cyclopenthiazide Inferred relationship Existential restriction modifier
Product containing cyclopenthiazide Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Amiloride hydrochloride+cyclopenthiazide Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Product containing cyclopenthiazide and oxprenolol Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing amiloride and cyclopenthiazide Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Allergy to cyclopenthiazide Causative agent True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has basis of strength substance False Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet Has basis of strength substance True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet Has basis of strength substance False Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet Has precise active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing cyclopenthiazide and oxprenolol in oral dose form (medicinal product form) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has precise active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet Has precise active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing cyclopenthiazide in oral dose form (medicinal product form) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Amiloride + Cyclopenthiazide Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Cyclopenthiazide Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing only cyclopenthiazide and oxprenolol (medicinal product) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing only amiloride and cyclopenthiazide in oral dose form (medicinal product form) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing only cyclopenthiazide and oxprenolol in oral dose form (medicinal product form) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing only cyclopenthiazide in oral dose form (medicinal product form) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 1
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has basis of strength substance True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has precise active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet Has basis of strength substance True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet Has precise active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier 2
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Cyclopenthiazide 500mcg tablet - product Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Amiloride hydrochloride+cyclopenthiazide 2.5mg/250micrograms tablet - product Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Navidrex 500mcg tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Navispare tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Navidrex 500microgram tablets (Goldshield Healthcare Ltd) Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Cyclopenthiazide 500microgram tablets 28 tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Amiloride 2.5mg / Cyclopenthiazide 250microgram tablets 28 tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide 160mg/0.25mg modified-release tablets 28 tablet Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Navidrex 500microgram tablets (Goldshield Healthcare Ltd) 28 tablet 2 x 14 tablets Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet Has specific active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide 160mg/0.25mg modified-release tablets 28 tablet Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Navidrex 500microgram tablets (Goldshield Healthcare Ltd) Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Navidrex 500microgram tablets (Goldshield Healthcare Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Cyclopenthiazide 500microgram tablets 28 tablet Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Amiloride 2.5mg / Cyclopenthiazide 250microgram tablets 28 tablet Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Product containing precisely amiloride hydrochloride 2.5 milligram and cyclopenthiazide 250 microgram/1 each conventional release oral tablet Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Navispare 2.5mg/250microgram tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide 160mg/0.25mg modified-release tablets Has active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide 160mg/0.25mg modified-release tablets Has specific active ingredient False Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide 160mg/0.25mg modified-release tablets Has active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier
Co-prenozide 160mg/0.25mg modified-release tablets Has specific active ingredient True Cyclopenthiazide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start